Electrochemical determination of imatinib mesylate using TbFeO3/g-C3N4 nanocomposite modified glassy carbon electrode
Authors:
- Mahin BaladiMBMahin Baladi
- Hakimeh TeymouriniaHTHakimeh Teymourinia
- Elmuez A. DawiEDElmuez A. Dawi
- Mahnaz AmiriMAMahnaz Amiri
- Ali RamazaniARAli Ramazani
- Masoud Salavati-NiasariMSMasoud Salavati-Niasari
Open Access
- 1 August 2023
- journal article
- research article
- Published by Scientific Scholar in Arabian Journal of Chemistry
- Vol. 16 (8)
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- Capillary electrophoresis method for plasmatic determination of imatinib mesylate in chronic myeloid leukemia patientsElectrophoresis, 2011
- Polymeric nanocomposite materials: Preparation and characterization of star-shaped PbS nanocrystals and their influence on the thermal stability of acrylonitrile–butadiene–styrene (ABS) copolymerPolyhedron, 2011
- Synthesis and characterization of ZnO nanocrystals from thermolysis of new precursorChemical Engineering Journal, 2009
- Phase I and Pharmacokinetic Study of Imatinib Mesylate in Patients With Advanced Malignancies and Varying Degrees of Renal Dysfunction: A Study by the National Cancer Institute Organ Dysfunction Working GroupJournal of Clinical Oncology, 2008
- Treatment for chronic myelogenous leukemia: the long road to imatinibJournal of Clinical Investigation, 2007
- Synthesis and characterization of alumina-supported Mn(II), Co(II), Ni(II) and Cu(II) complexes of bis(salicylaldiminato)hydrazone as catalysts for oxidation of cyclohexene with tert-buthylhydroperoxideApplied Catalysis A: General, 2005
- Voltammetric determination of Imatinib (Gleevec) and its main metabolite using square-wave and adsorptive stripping square-wave techniques in urine samplesTalanta, 2005
- Alumina-supported FeCl3, MnCl2, CoCl2, NiCl2, CuCl2, and ZnCl2 as catalysts for the benzylation of benzene by benzyl chlorideJournal of Molecular Catalysis A: Chemical, 2004
- Specific Targeted Therapy of Chronic Myelogenous Leukemia with ImatinibPharmacological Reviews, 2003
- Activity of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in the Blast Crisis of Chronic Myeloid Leukemia and Acute Lymphoblastic Leukemia with the Philadelphia ChromosomeNew England Journal of Medicine, 2001